TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Columbus, OH
- Industry: Pharmaceutical Preparation Manufacturing
Contract Details
- Notice ID
- S-195396
- Opportunity Type
- Special Notice
- Agency
- ENERGY, DEPARTMENT OF
- Sub-Agency
- ENERGY, DEPARTMENT OF
- Office
- TRIAD - DOE CONTRACTOR
- Posted Date
- Thursday, June 4, 2026
- Response Deadline
- Friday, December 4, 2026
- PSC Code
- 6505
- Set-Aside
- No Set Aside
- Place of Performance
- Columbus, OH, 43201
- Status
- Active
Description
This technology from scientists at Los Alamos National Laboratory represents a novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these capabilities position the technology as a differentiated and scalable solution that can unlock new commer
Why This Opportunity Matters
ENERGY, DEPARTMENT OF is seeking responses for pharmaceutical preparation manufacturing with a set-aside for No Set Aside businesses in Columbus, OH. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
